Precigen
PGEN
165 hedge funds and large institutions have $265M invested in Precigen in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 25 closing their positions.
127% more call options, than puts
Call options by funds: $880K | Put options by funds: $387K
45% more capital invested
Capital invested by funds: $182M → $265M (+$82.8M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 52
2% less funds holding
Funds holding: 169 → 165 (-4)
5.41% less ownership
Funds ownership: 65.46% → 60.06% (-5.4%)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.03M |
| 2 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$904K |
| 3 |
Axa
Paris,
France
|
+$818K |
| 4 |
Man Group
London,
United Kingdom
|
+$410K |
| 5 |
KHCM
Kettle Hill Capital Management
New York
|
+$327K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$7.5M |
| 2 |
Millennium Management
New York
|
-$5.59M |
| 3 |
Renaissance Technologies
New York
|
-$1.39M |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$1.18M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$1.16M |
PGEN Hedge Fund Activity: Q3 2022 in Review
165 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2022, worth a combined $265M — up 45% from $182M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of PGEN and 22 opened new positions — a net loss of 3 holders — while 52 trimmed existing stakes and 48 added.
The largest buyer was Marshall Wace, opening a new position worth an estimated $1.03M. The largest seller was Miller Value Partners, exiting entirely with an estimated $7.5M sold.
- 165 institutional investors held Precigen (PGEN) as of Q3 2022, down from 169 in Q2 2022.
- Funds reported $265M of Precigen stock for Q3 2022, up 45% quarter-over-quarter.
- 22 funds opened new Precigen positions in Q3 2022 and 25 closed out, a net change of -3 holders.
- The largest Precigen buyer in Q3 2022 was Marshall Wace, an estimated $1.03M added.
- The largest Precigen seller in Q3 2022 was Miller Value Partners, an estimated $7.5M sold.
Based on aggregated 13F filings for Q3 2022.